Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Jupiter Neurosciences, Inc. (NASDAQ: JUNS)
JUNS Stock Predictions and Ratings
WSX Rating:
STRONG SELL
WSX Forecast (1yr):
-58.80%
Analyst Rating:
NOT AVAILABLE
Analyst Forecast (1yr):
NOT AVAILABLE
JUNS Stock Analysis
JUNS
PE Ratio:
JUNS
PEG Ratio:
Not Available
JUNS
Forward EPS Growth (12 month):
0.00%
JUNS
PS Ratio:
225.1
JUNS
PSG Ratio:
-5.7
JUNS
Forward Revenue Growth (12 month):
-39.40%
JUNS Articles
No data was found